Rupinta, Eduardo R.
HRN: 22-40-62 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/01/2023
CEFTRIAXONE 1G (VIAL)
01/01/2023
01/07/2023
IVT
2gm
Q24
COPD IN AE
Waiting Final Action